Essential Role for Cyclin D3 in Granulocyte Colony-Stimulating Factor-Driven Expansion of Neutrophil Granulocytes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The proliferation of neutrophil granulocyte lineage is driven largely by granulocyte colony-stimulating factor (G-CSF) acting via the G-CSF receptors. In this study, we show that mice lacking cyclin D3, a component of the core cell cycle machinery, are refractory to stimulation by the G-CSF. Consequently, cyclin D3-null mice display deficient maturation of granulocytes in the bone marrow and have reduced levels of neutrophil granulocytes in their peripheral blood. The mutant mice are unable to mount a normal response to bacterial challenge and succumb to microbial infections. In contrast, the expansion of hematopoietic stem cells and lineage-committed myeloid progenitors proceeds relatively normally in mice lacking cyclin D3, revealing that the requirement for cyclin D3 function operates at later stages of neutrophil development. Importantly, we verified that this requirement is specific to cyclin D3, as mice lacking other G(1) cyclins (D1, D2, E1, or E2) display normal granulocyte counts. Our analyses revealed that in the bone marrow cells of wild-type mice, activation of the G-CSF receptor leads to upregulation of cyclin D3. Collectively, these results demonstrate that cyclin D3 is an essential cell cycle recipient of G-CSF signaling, and they provide a molecular link of how G-CSF-dependent signaling triggers cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given the reliance of myeloid development in the mouse on cyclin D2- and D3-driven CDK6 (62, 71, 72), these results might have been anticipated.”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677 · cited 1×
“It was previously shown that IL-1, IL-6, and TNF- are critically required to trigger a normal response to Listeria monocytogenes challenge (6, 11, 13, 26, 28).”
BackgroundGranulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Given that abnormal proliferation of hematopoietic cells is an underlying cause of several human diseases, such as leukemias and aplastic syndromes (16, 24, 42), it is important to elucidate the mechanisms that govern normal proliferation of these lineages.”
BackgroundLiving with or without cyclins and cyclin-dependent kinases
Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089
Granulocyte colony-stimulating factor and its receptor
Demetri, G., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,064
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Lieschke, G., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K., Basu, S., Zhan, Y., & Dunn, A. (1994) · Blood · doi:10.1182/blood.v84.6.1737.1737 · Cited by 962
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 2×
“Northern blot analyses were performed as described previously (32, 39).”
BackgroundMethodSelf-citationGranulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. (1991) · Blood · doi:10.1182/blood.v78.11.2791.bloodjournal78112791 · Cited by 825
Cited by
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
“Moreover, CDK6 had not yet been discovered ( 12 ), and the demonstration that the ability of p16 INK4a to arrest the cell cycle depended upon functional RB had not thus far been fi rmly established ( 33–35 ).”
InfluentialPanopoulos, A. D., & Watowich, S. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.03.002 · Cited by 394
The Requirement for Cyclin D Function in Tumor Maintenance
Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., Signoretti, S., Look, A. T., Kung, A. L., von Boehmer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.015 · Cited by 342
“Analyses of peripheral blood revealed modestly decreased red and white blood cell counts (Figures S2D–S2F), again resembling the abnormalities found in cyclin D3 / animals (Sicinska et al., 2006).”
BackgroundMethodResultCyclin D-CDK4/6 functions in cancer
(2020) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.02.002 · Cited by 218
Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
Sawai, C. M., Freund, J., Oh, P., Ndiaye-Lobry, D., Bretz, J. C., Strikoudis, A., Genesca, L., Trimarchi, T., Kelliher, M. A., Clark, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.016 · Cited by 183
“Each knockout mouse was viable, but displayed distinct tissue-specific defects (Ciemerych et al., 2002; Kozar et al., 2004; Sicinski et al., 1995, 1996; Sicinska et al., 2003, 2006).”
InfluentialImmunomodulation by anticancer cell cycle inhibitors
Petroni, G., Formenti, S. C., Chen-Kiang, S., & Galluzzi, L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0300-y · Cited by 163
Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis
Kreisel, D., Sugimoto, S., Tietjens, J., Zhu, J., Yamamoto, S., Krupnick, A. S., Carmody, R. J., & Gelman, A. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42596 · Cited by 127
Rojas, A., Kong, S. W., Agarwal, P., Gilliss, B., Pu, W. T., & Black, B. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00717-08 · Cited by 122
“Consistent with the overlapping expression of D-cyclin proteins, mice lacking any single Dcyclin are viable and display only narrow, highly tissue-restricted phenotypes with no obvious cardiac defects (21, 26, 69, 70).”
BackgroundCyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number
Sankaran, V. G., Ludwig, L. S., Sicinska, E., Xu, J., Bauer, D. E., Eng, J. C., Patterson, H. C., Metcalf, R. A., Natkunam, Y., Orkin, S. H., et al. (2012) · Genes & Development · doi:10.1101/gad.197020.112 · Cited by 122
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
Bonelli, M. A., Monica, S. L., Fumarola, C., & Alfieri, R. R. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113676 · Cited by 112
Kim, S., Tiedt, R., Loo, A., Horn, T., Delach, S., Kovats, S., Haas, K., Engstler, B. S., Cao, A., Pinzon-Ortiz, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26215 · Cited by 93
“Mouse knockout studies have indicated that myelosuppression is an anticipated on-target effect of CDK4/6 inhibition [32].”
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
Palmer, C. L., Boras, B. W., Pascual, B., Li, N., Li, D., Garza, S. J., Huser, N. H., Yuan, J. T., Cianfrogna, J. A., Sung, T., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.006 · Cited by 86
Immunomodulatory Roles of Cell Cycle Regulators
Laphanuwat, P., & Jirawatnotai, S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00023 · Cited by 71
“The cyclin D3-deficient granulocytes were refractory to granulocyte colonystimulating factor (G-CSF)-driven expansion (Sicinska et al., 2006).”
Bockstaele, L., Coulonval, K., Kooken, H., Paternot, S., & Roger, P. P. (2006) · Cell Division · doi:10.1186/1747-1028-1-25 · Cited by 86
Hoshii, T., Kasada, A., Hatakeyama, T., Ohtani, M., Tadokoro, Y., Naka, K., Ikenoue, T., Ikawa, T., Kawamoto, H., Fehling, H. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320265111 · Cited by 64
“Interestingly, Cyclin D3 deficiency reduces BM cellularity caused by defective expansion of granulocytes, but not of hematopoietic stem cells and GMPs (30), just as we observed in Raptor-deficient mice.”
BackgroundTo Cycle or Fight—CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity
Ameratunga, M., Kipps, E., Okines, A. F. C., & Lopez, J. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1999 · Cited by 62
“CDK6 is expressed at high levels in hematopoietic cells (14), and Cdk6 deficiency is characterized by subtle defects in the hematopoietic system, such as defects in thymocyte development (13, 15).”
BackgroundInfluentialNew Approaches to Target T-ALL
Roti, G., & Stegmaier, K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00170 · Cited by 57
“Mice lacking cyclin-D1 are resistant to ErbB2-driven carcinoma (69–72), while cyclinD3-null animals are refractory to NOTCH1-induced T-ALL (73).”
BackgroundD-Type Cyclins in Development and Disease
Saleban, M., Harris, E. L., & Poulter, J. A. (2023) · Genes · doi:10.3390/genes14071445 · Cited by 53
Role of key regulators of the cell cycle in maintenance of hematopoietic stem cells
Matsumoto, A., & Nakayama, K. I. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.004 · Cited by 60
Less-well known functions of cyclin/CDK complexes
Palmer, N., & Kaldis, P. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.003 · Cited by 51
pRb-Dependent Cyclin D3 Protein Stabilization Is Required for Myogenic Differentiation
Santa, F. D., Albini, S., Mezzaroma, E., Baron, L., Felsani, A., & Caruso, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02199-06 · Cited by 46
“Cyclin D3 knockout mice are viable and display focal defects in the maturation of specific myelolymphocyte precursors (9, 59, 60).”
BackgroundArgiropoulos, B., Yung, E., Xiang, P., Lo, C., Kuchenbauer, F. C., Palmqvist, L., Reindl, C., Heuser, M., Sekulovic, S., Rosten, P., et al. (2010) · Blood · doi:10.1182/blood-2009-06-225573 · Cited by 41
Luca, G., Ferretti, R., Bruschi, M., Mezzaroma, E., & Caruso, M. (2013) · Stem Cells · doi:10.1002/stem.1487 · Cited by 42
Weng, H., Huang, H., Zhao, P., Zhou, H., & Qu, L. (2012) · RNA Biology · doi:10.4161/rna.21210 · Cited by 38
“Emerging research has supported the role of CCND3 in the development of normal and cancer cells in addition to its basic role in cell cycle regulation and proliferation.(6-23) However, study of the regulation of CCND3 in cells is yet to be fully defined.”
BackgroundKowalski, K., Archacki, R., Archacka, K., Stremińska, W., Paciorek, A., Gołąbek, M., Ciemerych, M. A., & Brzóska, E. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12092 · Cited by 31
“Starting from the day of injury, animals were subcutaneously injected with G-CSF (250ng per 1g of body weight).(27) G-CSF was adminis-”
MethodSu, J., Zhou, H., Tao, Y., Guo, J., Guo, Z., Zhang, S., Zhang, Y., Huang, Y., Tang, Y., Dong, Q., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120707 · Cited by 29
Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1lo hematopoietic stem cells
Cellot, S., Krošl, J., Chagraoui, J., Meloche, S., Humphries, R. K., & Sauvageau, G. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.013 · Cited by 40
“Moreover, the documented decrease in Cyclin D3 in cultured cells sustaining self-renewal parallels the findings of Cyclin D3 null mice, reported to have a normal stem and progenitor pool, but a differentiation arrest [39].”
ResultMekonnen, L. B., Tadesse, S., Lenjisa, J. L., Yu, M., Noll, B. D., Heinemann, G. K., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Beck, A. R., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.09.012 · Cited by 25
Torres-Guzmán, R., Ganado, M. P., Mur, C., Marugán, C., Baquero, C., Yang, Y., Zeng, Y. A., Bian, H., Du, J., de Dios, A., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28249 · Cited by 18
Giannattasio, S., Giacovazzo, G., Bonato, A., Caruso, C., Luvisetto, S., Coccurello, R., & Caruso, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31090-5 · Cited by 18
A curious case of cyclin-dependent kinases in neutrophils
Syahirah, R., Hsu, A. Y., & Deng, Q. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ru1021-573r · Cited by 15
Promiscuous and lineage-specific roles of cell cycle regulators in haematopoiesis.
Myatt, S. S., & Lam, E. W. ‐. (2007) · Cell Division · doi:10.1186/1747-1028-2-6 · Cited by 19
“In addition, cyclin D3 null mice also display defects in the maturation of granulocytes in the bone marrow and have reduced levels of circulating neutrophil granulocytes [16].”
BackgroundGenistein Protects Hematopoietic Stem Cells against G-CSF–Induced DNA Damage
Souza, L. R., Silva, E., Calloway, E., Küçük, Ö., Rossi, M. R., & McLemore, M. L. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0295 · Cited by 10
“Mice lacking cyclin D3 show impaired neutrophil development, however, all D1 / , D2 / , D3 / single knockoutmice present normal myelopoiesis (48).”
BackgroundThe D-Type Cyclins: A Historical Perspective
Sherr, C. J., & Siciński, P. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_1 · Cited by 16
Mammalian Development and Cancer: A Brief History of Mice Lacking D-Type Cyclins or CDK4/CDK6
Kalaszczyńska, I., & Ciemerych, M. A. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_2 · Cited by 4
Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics
Malumbres, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_10 · Cited by 5
The effect of rhG-CSF on spleen transcriptome in mouse leukopenia model induced by cyclophosphamide
Guo, H., Sun, F., Huang, W., Liu, Z., Zhang, S., Zhou, Q., & Liang, C. (2014) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2013.869696 · Cited by 3
Matos, T. G. D. F. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2007.tde-23112007-105248 · Cited by 4
SHORT TITLE: Genistein limits DNA Damage
Souza, L. R., Silva, E., Calloway, E., Küçük, Ö., Rossi, M. R., & McLemore, M. L. (2014)
Torres-Guzmán, R., Ganado, M. P., Cecilia, M., Carlos, M. F., Baquero, C., Yang, Y., Zeng, Y. A., Huimin, B., Jian, D., Alfonso, D. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.15.468648
New Agents for the Treatment of T-Cell Acute Lymphoblastic Leukemia
Raikar, S. S., Teachey, D. T., & Gossai, N. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-85147-7_14
(2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f20347
Zhang, Y., Hao, Q., Que, C., Wang, X., Li, Y., Li, W., Wang, Q., Zhu, Y., & Zhou, K. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111460
Discovery of INCB127443: A Potent and Orally Available Inhibitor of Cyclin-Dependent Kinase 2
Mukai, K., Smith, B. R., Ye, Q., Epling, L. B., Lai, C., Huo, L., Bowen, S., Drake, K., Kennedy, K., Boer, J., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01506
Metadata
- Authors
- Sicinska, E., Lee, Y.-M., Gits, J., Shigematsu, H., Yu, Q., Rebel, V. I., Geng, Y., Marshall, C. J., Akashi, K., Dorfman, D. M., Touw, I. P., & Sicinski, P.
- Affiliations
- Department of Cancer Biology
- Harvard University (US)
- Erasmus MC (NL)
- The University of Texas at San Antonio Health Science Center (US)
- Institute of Cancer Research (GB)
- Brigham and Women's Hospital (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-11-01
- Volume
- 26
- Issue
- 21
- Pages
- 8052-8060
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1636755
- OpenAlex
- W2111636772
- Cited by
- 45
- References
- 46
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2015: 3 · 2014: 5 · 2013: 1 · 2012: 5
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Leukemia and Lymphoma Society
- KWF Kankerbestrijding
- National Institutes of Health
- National Cancer Institute (R01CA108420, P01CA109901)
- Topics
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cyclin D3, granulocyte colony-stimulating factor, neutrophils, granulocyte maturation, cell cycle, G1 cyclins, hematopoiesis, myeloid progenitor cells, bacterial infection susceptibility, bone marrow
- MeSH terms
- Animals, Bacterial Infections, Bone Marrow Cells, Cell Cycle, Disease Susceptibility, Hematopoietic Stem Cells, Humans, Mice, Inbred C57BL, Neutropenia, Neutrophils, Signal Transduction, Granulocyte Colony-Stimulating Factor, Receptors, Granulocyte Colony-Stimulating Factor, Cyclins, Mice, Knockout, Cell Lineage, Cell Proliferation, Mice, Cyclin D3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.